PROGNOSTIC STAGE III BREAST CANCER AJCC V8
Clinical trials for PROGNOSTIC STAGE III BREAST CANCER AJCC V8 explained in plain language.
Never miss a new study
Get alerted when new PROGNOSTIC STAGE III BREAST CANCER AJCC V8 trials appear
Sign up with your email to follow new studies for PROGNOSTIC STAGE III BREAST CANCER AJCC V8, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New vaccine trains immune system to hunt down breast cancer cells
⭐️ VACCINE ⭐️ OngoingThis study tests a DNA-based vaccine called STEMVAC in 33 people with early-stage triple negative breast cancer. The vaccine aims to teach the immune system to recognize and attack proteins found on breast cancer stem cells. The main goal is to see if the vaccine triggers a stron…
Matched conditions: PROGNOSTIC STAGE III BREAST CANCER AJCC V8
Phase: PHASE2 • Sponsor: University of Washington • Aim: ⭐️ VACCINE ⭐️
Last updated May 17, 2026 03:24 UTC
-
New drug combo targets BRCA cancers in early trial
Disease control OngoingThis early-phase trial tests a combination of two drugs—niraparib (a PARP inhibitor) and dostarlimab (an immunotherapy)—in people with BRCA-mutated breast, pancreas, or ovarian cancers that have spread or cannot be surgically removed. The goal is to see if the combo can shrink tu…
Matched conditions: PROGNOSTIC STAGE III BREAST CANCER AJCC V8
Phase: PHASE1 • Sponsor: University of Washington • Aim: Disease control
Last updated May 17, 2026 03:29 UTC
-
New drug combo aims to stop aggressive breast cancer in its tracks
Disease control OngoingThis phase 3 study tests whether adding tucatinib to the targeted therapy T-DM1 can better prevent HER2-positive breast cancer from coming back in high-risk patients. About 1,056 participants who still have cancer after initial treatment will receive either T-DM1 alone or T-DM1 p…
Matched conditions: PROGNOSTIC STAGE III BREAST CANCER AJCC V8
Phase: PHASE3 • Sponsor: Alliance for Clinical Trials in Oncology • Aim: Disease control
Last updated May 17, 2026 03:29 UTC
-
Radiation before surgery may improve breast cancer outcomes
Disease control OngoingThis study tests whether giving an extra dose of radiation (a boost) before breast cancer surgery is safe and effective. About 103 people with early-stage, non-metastatic breast cancer will receive the boost, followed by standard radiation and surgery. The goal is to better targe…
Matched conditions: PROGNOSTIC STAGE III BREAST CANCER AJCC V8
Phase: NA • Sponsor: Rutgers, The State University of New Jersey • Aim: Disease control
Last updated May 17, 2026 03:25 UTC
-
Texts and talks: a new way to help breast cancer patients stay on track with meds
Symptom relief OngoingThis study tests whether adding text message reminders and/or telephone counseling helps breast cancer patients take their daily hormone therapy pills more consistently. About 1,167 women with early-stage hormone receptor-positive breast cancer will be followed for up to two year…
Matched conditions: PROGNOSTIC STAGE III BREAST CANCER AJCC V8
Phase: PHASE3 • Sponsor: Alliance for Clinical Trials in Oncology • Aim: Symptom relief
Last updated May 17, 2026 03:30 UTC
-
Walking through chemo: study tests exercise for older breast cancer patients
Symptom relief OngoingThis study looks at whether a regular exercise program is possible for women aged 65 and older who are receiving chemotherapy for early-stage breast cancer. Participants will do walking and arm exercises during their treatment. The goal is to see if exercise can help reduce chemo…
Matched conditions: PROGNOSTIC STAGE III BREAST CANCER AJCC V8
Phase: NA • Sponsor: M.D. Anderson Cancer Center • Aim: Symptom relief
Last updated May 15, 2026 11:54 UTC
-
New web tool aims to ease life after breast cancer for young women
Symptom relief OngoingThis study tests a web-based portal called YES that helps young breast cancer survivors (ages 15-39) track and manage their symptoms. About 400 women who had early-stage breast cancer within the last 3 years will use the portal or receive standard care. The goal is to see if the …
Matched conditions: PROGNOSTIC STAGE III BREAST CANCER AJCC V8
Phase: NA • Sponsor: Ohio State University Comprehensive Cancer Center • Aim: Symptom relief
Last updated May 08, 2026 12:02 UTC
-
Healing words: writing study aims to ease stress for chinese breast cancer survivors
Symptom relief OngoingThis study looks at whether a culturally tailored expressive writing program can improve quality of life and reduce stress in Chinese immigrant women who had breast cancer (stages 0 to III). About 256 women who finished primary treatment in the last 5 years will write about their…
Matched conditions: PROGNOSTIC STAGE III BREAST CANCER AJCC V8
Phase: NA • Sponsor: M.D. Anderson Cancer Center • Aim: Symptom relief
Last updated May 05, 2026 11:55 UTC
-
New study aims to help older breast cancer patients make chemotherapy choices
Knowledge-focused OngoingThis study looks at how women aged 65 and older with early-stage breast cancer make decisions about chemotherapy. Researchers will interview patients and doctors to understand what information they need. The goal is to create a tool that helps patients and doctors weigh the risks…
Matched conditions: PROGNOSTIC STAGE III BREAST CANCER AJCC V8
Phase: NA • Sponsor: M.D. Anderson Cancer Center • Aim: Knowledge-focused
Last updated May 17, 2026 03:31 UTC
-
New study aims to predict who will suffer nerve damage from chemo
Knowledge-focused OngoingThis study follows over 1,300 people with breast, lung, or ovarian cancer who are starting a type of chemotherapy called taxane. The goal is to find out which patients are more likely to develop nerve damage (peripheral neuropathy), which can cause tingling or numbness in the han…
Matched conditions: PROGNOSTIC STAGE III BREAST CANCER AJCC V8
Sponsor: SWOG Cancer Research Network • Aim: Knowledge-focused
Last updated May 17, 2026 03:31 UTC
-
Gene test may guide breast cancer treatment choices
Knowledge-focused OngoingThis study looks at whether testing tumor genes can help predict if HER2-negative breast cancer will respond to chemotherapy or hormone therapy. About 1,100 people with stage I to III breast cancer will have their tumor samples analyzed. The goal is to see if this genetic testing…
Matched conditions: PROGNOSTIC STAGE III BREAST CANCER AJCC V8
Phase: PHASE2 • Sponsor: M.D. Anderson Cancer Center • Aim: Knowledge-focused
Last updated May 17, 2026 03:31 UTC
-
Can genes predict chemo nerve damage? new study focuses on african american women
Knowledge-focused OngoingThis study looks at whether certain genes make African American women with breast cancer more likely to develop nerve damage from chemotherapy drugs like docetaxel or paclitaxel. About 249 women with stage I-III breast cancer took part. The goal is to find out if a genetic test c…
Matched conditions: PROGNOSTIC STAGE III BREAST CANCER AJCC V8
Phase: PHASE2 • Sponsor: ECOG-ACRIN Cancer Research Group • Aim: Knowledge-focused
Last updated May 17, 2026 03:26 UTC
-
Cancer survivors share fertility hopes in new survey
Knowledge-focused OngoingThis study surveys women aged 18-45 who have had gynecological or breast cancer to learn how they think about having a baby after treatment. Researchers will use the results to create better information for patients and survivors about balancing cancer care and family planning. T…
Matched conditions: PROGNOSTIC STAGE III BREAST CANCER AJCC V8
Sponsor: M.D. Anderson Cancer Center • Aim: Knowledge-focused
Last updated May 17, 2026 03:26 UTC
-
New study tracks shoulder pain after breast cancer radiation
Knowledge-focused OngoingThis study looks at shoulder and arm problems in women with lymph-node positive breast cancer who receive radiation therapy. Researchers want to see how often these problems happen and how severe they are one year after treatment. The goal is to help doctors choose the best radia…
Matched conditions: PROGNOSTIC STAGE III BREAST CANCER AJCC V8
Phase: NA • Sponsor: Ohio State University Comprehensive Cancer Center • Aim: Knowledge-focused
Last updated May 15, 2026 11:53 UTC